HealthQuill China
The global diabetic population has risen fourfold to 828 million during the last three decades, with more than a quarter living in India, according to an analysis published in The Lancet.
Drugs Health Pharma

Global diabetic population rose fourfold to 828 million in 2022

The global diabetic population has risen fourfold to 828 million during the last three decades, with more than a quarter living in India,.

Read More
The US Food and Drug Administration has greenlighted Pfizer Inc.’s respiratory syncytial virus vaccine (RSV) Abrysvo for treating lower respiratory tract disease in people 18-59 years.
Pharma

Pfizer to invest $1b in China over five years, strengthens biotech footprint

HQ Times November 8, 2024: Pfizer under activist investor pressure is busy turning its performance around and has decided to expand its presence.

Read More
GSK Plc will pay China’s privately-held Chimagen Biosciences $300 million upfront to develop and commercialise a T-cell engager to treat autoimmune diseases.
Drugs Health Medical

GSK to pay Chimagen $300m upfront to develop autoimmune drug 

GSK Plc., will pay China’s privately-held Chimagen Biosciences $300 million upfront to develop and commercialise a T-cell engager to treat autoimmune diseases.

Read More
Tuberculosis has emerged as the world’s top infectious disease with about 8.2 million people newly diagnosed with the illness last year — the highest on records since WHO began global monitoring in 1995.
Drugs Health Medical

Tuberculosis was the world’s top infectious disease killer last year

Tuberculosis has emerged as the world’s top infectious disease with about 8.2 million people newly diagnosed with the illness last year — the.

Read More
china stocks up on emergency food supply
Climate Drugs Pharma

China boosts emergency food supply in response to climate events

HQ Team October 17, 2024: Extreme weather conditions and the increasing number of natural disaster events have forced China to take steps to.

Read More
Genentech, a member of the Roche Group, will acquire a portfolio of CDK inhibitors to treat breast cancer from Regor Pharmaceuticals for an upfront payment of $850 million.
Drugs Health Pharma

Roche arm to buy breast cancer portfolio from Regor for $850 million

Genentech, a member of the Roche Group, will acquire a portfolio of CDK inhibitors to treat breast cancer from Regor Pharmaceuticals for an.

Read More
Surgery-free cataracts may be possible in the future after researchers at the National Institutes of Health discovered a protein that can reverse and manage the clouding of the eye’s lens or lead to the development of a drug.
Drugs Health Pharma

Protein discovery in animal studies holds hope for surgery-free cataract

Surgery-free cataracts may be possible in the future after researchers at the National Institutes of Health discovered a protein that can reverse and.

Read More
The US Food and Drug Administration approved AstraZeneca Plc’s Fasenra for treatment in adult patients with a rare inflammation of blood vessels.
Drugs Health Pharma

AstraZeneca’s rare disease drug Fasenra gets US regulator’s nod

The US Food and Drug Administration approved AstraZeneca Plc’s Fasenra for treatment in adult patients with a rare inflammation of blood vessels.

Read More
A global goal to reduce methane emissions “ seems as distant as a desert oasis” now, as about two-thirds of it comes from human activities such as fossil fuels, agriculture and landfills, researchers find.
Climate Health Pharma

Global goal to cut methane emissions as distant as a ‘desert oasis’

A global goal to reduce methane emissions “ seems as distant as a desert oasis” now, as about two-thirds of it comes from.

Read More
Summit Therapeutics Inc.’s investigational drug ivonescimab helps lung cancer patients to cut the risk of progression or death from the disease by 48%, the latest results of the company's trials reveal.
Drugs Health Pharma

Summit’s lung cancer drug reduces risk of disease progression by 48%

Summit Therapeutics Inc.’s investigational drug ivonescimab helps lung cancer patients to cut the risk of progression or death from the disease by 48%,.

Read More